Literature DB >> 8641801

Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease.

M Hauge1, C Jespersgaard, K Poulsen, M Kilian.   

Abstract

To evaluate the genetic diversity and relationships in a collection of 85 Danish strains of Streptococcus agalactiae (group B streptococcus) we have performed restriction fragment length polymorphism analysis on EcoRI- and MspI-digested whole-cell DNA using as probes rRNA, DNA fragments representing the genes encoding hyaluronidase, C5a-peptidase, alpha-antigen, and beta-antigen as well as two randomly selected genomic DNA fragments for which the coding potential is unknown. In addition, we have assayed for expression of hyaluronidase activity and beta-antigen. Combined analyses of our data and those previously obtained by multilocus enzyme electrophoresis and serotyping revealed a population separating into six major lineages that correlate with individual serotypes. The significant linkage disequilibrium of alleles indicates that the S. agalactiae population examined is predominantly clonal. Notably, strains expressing the serotype III capsule divide into two distant evolutionary lineages, of which one lacks expression of hyaluronidase activity. Six North American isolates of serotype III clustered together with multiple Danish serotype III strains, showing that the combinations of characters on which the phylogenetic tree was based are conserved worldwide. Occurrence of beta-antigen correlated with a specific version of the alpha-antigen gene and was exclusively associated with a single major phylogenetic lineage. Comparisons with the clinical history of the strains revealed no evidence of differences in pathogenic potential among the six major genetic divisions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641801      PMCID: PMC173857          DOI: 10.1128/iai.64.3.919-925.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.

Authors:  C E Rubens; M R Wessels; L M Heggen; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.

Authors:  T W Milligan; C J Baker; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms.

Authors:  R F Smith; N P Willett
Journal:  Appl Microbiol       Date:  1968-09

5.  Evolutionary genetics of the encapsulated strains of Haemophilus influenzae.

Authors:  J M Musser; J S Kroll; E R Moxon; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Ibc proteins as serotype markers of group B streptococci.

Authors:  L Bevanger
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1983-08

7.  Clonal diversity of the Streptococcus mitis biovar 1 population in the human oral cavity and pharynx.

Authors:  J Hohwy; M Kilian
Journal:  Oral Microbiol Immunol       Date:  1995-02

8.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Authors:  J M Musser; S J Mattingly; R Quentin; A Goudeau; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

9.  Group B streptococcal carriage and disease: a 6-year prospective study.

Authors:  H C Dillon; S Khare; B M Gray
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

10.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  28 in total

1.  Mutually exclusive distribution of IS1548 and GBSi1, an active group II intron identified in human isolates of group B streptococci.

Authors:  M Granlund; F Michel; M Norgren
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  ISSa4-based differentiation of Streptococcus agalactiae strains and identification of multiple target sites for ISSa4 insertions.

Authors:  Alexander Dmitriev; Adong Shen; Xuzhuang Shen; Yonghong Yang
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

3.  Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study.

Authors:  Feng-Ying C Lin; April Whiting; Elisabeth Adderson; Shinji Takahashi; Diane Marie Dunn; Robert Weiss; Parvin H Azimi; Joseph B Philips; Leonard E Weisman; Joan Regan; Penny Clark; George G Rhoads; Carl E Frasch; James Troendle; Patricia Moyer; John F Bohnsack
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  High-virulence clone of group B streptococci unable to grow at high temperatures is present in serotypes other than type III.

Authors:  Gerardo C Palacios; Maria N Gonzalez; Magdalena Beltran; Jose L Arredondo; Javier Torres; Fortino Solorzano
Journal:  Curr Microbiol       Date:  2006-12-13       Impact factor: 2.188

5.  Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999.

Authors:  John F Bohnsack; April Whiting; Marcelo Gottschalk; Diane Marie Dunn; Robert Weiss; Parvin H Azimi; Joseph B Philips; Leonard E Weisman; George G Rhoads; Feng-Ying C Lin
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

6.  Genetic diversity of rRNA operons of unrelated Streptococcus agalactiae strains isolated from cerebrospinal fluid of neonates suffering from meningitis.

Authors:  S Chatellier; H Huet; S Kenzi; A Rosenau; P Geslin; R Quentin
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

7.  Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.

Authors:  Sarah Teatero; Allison McGeer; Donald E Low; Aimin Li; Walter Demczuk; Irene Martin; Nahuel Fittipaldi
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

8.  Molecular subtyping and characterization of bovine and human Streptococcus agalactiae isolates.

Authors:  Sharinne Sukhnanand; Belgin Dogan; Maranatha O Ayodele; Ruth N Zadoks; Mary Patricia J Craver; Nellie B Dumas; Ynte H Schukken; Kathryn J Boor; Martin Wiedmann
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Emergence and global dissemination of host-specific Streptococcus agalactiae clones.

Authors:  Uffe B Skov Sørensen; Knud Poulsen; Claudia Ghezzo; Immaculada Margarit; Mogens Kilian
Journal:  MBio       Date:  2010-08-24       Impact factor: 7.867

10.  Epidemiology of and prenatal molecular distinction between invasive and colonizing group B streptococci in The Netherlands and Taiwan.

Authors:  E van Elzakker; R Yahiaoui; C Visser; P Oostvogel; A Muller; Y-R Ho; J-J Wu; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-03-31       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.